GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
49 hedge funds and large institutions have $94M invested in Genocea Biosciences, Inc. in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 47 → 49 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
49
Holding in Top 10
2
Calls
$127K
Puts
$11K
Top Buyers
| 1 | +$1.76M | |
| 2 | +$603K | |
| 3 | +$469K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$217K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$195K |
Top Sellers
| 1 | -$1.27M | |
| 2 | -$1.08M | |
| 3 | -$305K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$225K |
| 5 |
Millennium Management
New York
|
-$120K |